skc
Goldmember
- Joined
- 12 August 2008
- Posts
- 8,277
- Reactions
- 329
IMO there is only limited possible logical conclusions to draw when money is raised via a placement rather then a renounceable rights issue.
Financing History:
Refer Changes in Capital Stock line item in the historical cash flow statements:
View attachment 57962
Fund raising in an annual event for these guys. The $8m is small relative to 2013 raising. They had $2m on balance sheet as at 30 June 2013 and generally maintain that sort of level. They have no debt worth talking of. 2013 EBITDA (prior to special items) was around $8m.
This doesn't look like anything other than a financing requirement, as advertised, to me. The insto/sophisticated placement is often preferred because it is fast and cheap for relatively small raisings - as this one was. It just happens in an (early) evening. In terms of 'unfairness' you can now buy in at the same price as the placement, if you manage to get queue priority at some stage.
If I was a retail holder, I'd be pissed that they did not do the raising shortly after the US FDA approval and dilution would have been slightly more than half of what it has been.
Ok Now you have really confused me Ive been reading your posts and im a holder in AHZ only because I liked what they where doing and am relativly new to the share market. So if share price drops lower than ..10 I can buy more shares lower than the spp prise?
Fund raising in an annual event for these guys. The $8m is small relative to 2013 raising. They had $2m on balance sheet as at 30 June 2013 and generally maintain that sort of level. They have no debt worth talking of. 2013 EBITDA (prior to special items) was around $8m.
This doesn't look like anything other than a financing requirement, as advertised, to me. The insto/sophisticated placement is often preferred because it is fast and cheap for relatively small raisings - as this one was. It just happens in an (early) evening. In terms of 'unfairness' you can now buy in at the same price as the placement, if you manage to get queue priority at some stage.
If I was a retail holder, I'd be pissed that they did not do the raising shortly after the US FDA approval and dilution would have been slightly more than half of what it has been.
1. Thats true, I think it was just the way it was done this time that drew our attention! (long term holders I mean.)
2. I dont think its likely that there will be any opportunity to buy in at below 10c, so if we current investors want more stock it will be better to just jump on the SPP. The flippers that did buy in the private placement have long gone, support is very strong at the 10c mark.
3. That's based on an assumption that the sp for a placement then would have been successful at a higher price than 10c I presume?
Interesting commentary, as always, craft. So which one do you believe is the motivation in this case? Or have you no real interest in AHZ and just passing commentary on the possible reasons?
Particularly distasteful use of a placement - The market is there to exchange ownership at negotiated prices. New investors should have to deal with current owners to establish positions not management - very rarely would it make sense for management working in the best interest of shareholders to make placements to new investors unless that investor was bringing something more then just passive ownership to the table.Other possibilities:
They were approached by new investor looking for a meaningful stake. Rights issue only allow existing investors to participate, and you never know about the liquidity / volume of renounceable rights trading.
They want money to come in before announcement of major news. E.g. A scheduled research report / milestone of which the outcome is genuinely unknown. Management wants to raise fund as a risk management measure, just in case the news turn out to be negative. Or a more sinister view: management is aware of a high possibility of bad outcome, so wants to raise money prior to a share price fall. (Note: just listing the possibilities, not implying anything one way or another).
Hi craft,Hi Galumay
No real interest in AHZ – just passing comment on the placement. Not sure which one is the case but there really is no good reason for a placement in my book. A ‘right’ of share ownership should be first offer to add more capital. If you are not extended that right it effects what valuation you should place on future growth expectations.
In terms of 'unfairness' you can now buy in at the same price as the placement, if you manage to get queue priority at some stage.
Hi craft,
I know you feel strongly about share placements and any other form of capital injection that involuntarily dilutes some of the holders on the register, so I was wondering if it is generally a big enough red flag for you to sell? Would you need a really good reason to keep holding? Or is it just a matter of updating your valuation to reflect the effects of the dilution (and any possible further dilutions in the future if management have a track record - which I assume you would check before taking a position).
1. ....stuff.....
Thanks, got it. I'm fairly similar actually - but do it more than once and there would have to be a bloody good reason.We crossed - the last paragraph of the previous post sort of gives an answer to this - Important but not absolute, as always it depends on the overall story.
You weren't confused after all. The SPP price will be at $0.10 which is in line with the insto/sophist placement. So, given the current price is $0.10, you can get set at the same price as the SPP. If it falls below that, the SPP will likely not be successful unless the punters who want more of the stock think they can't get set at the lower price due to lack of supply relative to demand. It will likely close undersubscribed in that event.
Can You please try and explain to me why people would want to sell for less than .10 that i dont understand!
Can You please try and explain to me why people would want to sell for less than .10 that i dont understand!
There are a ton of reasons. Here are some off the top of my head:
1. Investors change their minds about the prospects of the company and decide it is worth 9c. The valuation ranges for a company like this would be as much as 50% of the current stock price. Within that range, anything is fair game. If the people think it is worth 15c great, it's worth 15c and no valuation method would really dispute it too heavily. Just as easily it can go to 9c and there is little to say that this figure is wrong. The market just swings on instinct and herd behavior. No news is required at all.
2. There are a ton of stops and limits at 10c. If selling pressure pushes it through 10c, longs get squeezed out and liquidate. This pushes the price down suddenly.
3. Investors are sitting there knowing that only 30% of Placement volume has gone through as of tonight. Likely there will be patient money which are flippers that will take their time, they will cap out somewhere in the 11c to 12c range for instance. This will cap the stock performance for quite a while. It could be months as volume will decline again in the next week back to background noise levels. These flippers will not dominate volume as they currently are. They don't need to in order to control the price. Such investors may have more compelling ideas elsewhere and just need the money to be redeployed, so they sell.
4. Investors see the liquidation of some portion of their Placement as a whole trade which is tranched up for sale. Buy flip move on. Some of those tranches could easily be under water but no-one cares. For most people, this is a total piss ant.
On and on it goes....
Thanks peoples for your explainations.I can know see that theres heaps of reasonds and there is a hell of a lot more reading and learning I need to do.
Hope it doesnt go down much more or I would have done the mortal sin of potting all my eggs in on basket and I do know thats a no no>
I'd argue that it is not impossible to calculate any intrinsic value.(AHZ) is impossible to calculate any intrinsic value.
I'd argue that it is not impossible to calculate any intrinsic value.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?